NCT07349069 2026-03-19A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With High-Risk Early Breast CancerShandong Suncadia Medicine Co., Ltd.Phase 3 Recruiting4,800 enrolled